Health Trials

de Novo Lesions in Native Coronary Arteries

2

Review clinical trials related to de Novo Lesions in Native Coronary Arteries. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions

AGENT DCB STANCE is a prospective, multicenter, open-label, 1:1 randomized controlled study designed to assess the safety and effectiveness of a treatment strategy with the AGENT Drug-Coated Balloon compared to standard of care percutaneous coronary intervention (PCI) treatment with drug eluting stent (DES) and/or balloon angioplasty in patients with de novo coronary lesions. Subjects must have a de novo target lesion located in a native coronary artery.

Participants needed: 1,616
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Boston Scientific CorporationUpdated: Jul 2, 2026Locations: 62
Eligibility criteria

Subject must be at least 18 years of age. [+8]

Subject has other serious medical illness (e.g. cancer, congestive heart failure... [+24]

Read more
Status: Not yet recruiting

To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System

The study will evaluate the performance and safety of RisoR Crest Everolimus Eluting Coronary Stent System. A total of 2000 participants will be included in the study from India and Italy.

Participants needed: 2,000
Trial details
Age: 18-99Biological sex: AllType: InterventionalSponsor: Poly Medicure LimitedUpdated: Aug 1, 2025
Eligibility criteria

Age more than 18 years [+6]

Pregnant and lactating females [+10]

Read more